KARBAPENEMLERE DİRENÇLİ GRAM- NEGATİF BASİL ...
KARBAPENEMLERE DİRENÇLİ GRAM- NEGATİF BASİL ...
KARBAPENEMLERE DİRENÇLİ GRAM- NEGATİF BASİL ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
35. Cornaglia G, Mazzariol A, Fontana R. The astonishing complexity of antibiotics<br />
resistance. Clin Microbial Infect 2000;6(Suppl 3):93-4.<br />
36. Pool K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci 2004;61:2200-23.<br />
37. Gür D. Beta-laktamazların sınıflandırılması. Flora Dergisi 1996,1:80-6.<br />
38. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-<br />
lactamases and its correlation with molecular structure. Antimicrob Agents<br />
Chemother 1995;39:1211-33.<br />
39. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin<br />
Microbial Rev 1995;8:557-84.<br />
40. Gür D. Hastane infeksiyonlarında önem kazanan gram-negatif bakterilerde<br />
antibiyotiklere direnç mekanizmaları. Hastane İnfeksiyonları Dergisi 1997;1:38-45.<br />
41. Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by<br />
generations of beta-lactam antibiotics. Clin Infect Dis 1997;24,19-45.<br />
42. Yuluğ N. Beta-laktamazlar ve klinik açıdan önemi. ANKEM Derg 1997;11:205-7.<br />
43. Livermore DM. Beta-lactamase mediated resistance and opportunities for its<br />
control. J Antimicrob Chemother 1998;41(Suppl D):24-41.<br />
44. Danel F, Hall LMC, Gür D, Akalın HE, Livermore DM. Transferable production of<br />
PER-1 beta-lactamase in Pseudomonas aeruginosa. J Antimicrob Chemother<br />
1995;35:281-94.<br />
45. Vahapoğlu H, Hall LM, Mülazımoğlu L, et al. Resistance to extended spectrum<br />
cephalosporins, caused by PER-1 beta-lactamase in Salmonella typhimurium from<br />
Istanbul, Turkey. J Med Microbiol 1995;43:294-9.<br />
46. Hall LMC, Livermore DM, Gür D, Akova M, Akalın HE. OXA-11, an extended<br />
spectrum variant of OXA-10(PSE-)beta-lactamase from Pseudomonas aeruginosa.<br />
Antimicrob Agents Chemother 1993;37:1637-44.<br />
47. Amyes SGB. Carbapenemases. ANKEM Dergisi 1997;11(2):221-5.<br />
48. Hancock REW. Resistance mechanisms in Pseudomonas aeruginosa and other<br />
nonfermentative gram-negative bacteria. Clin Infect Disease 1989;27(Suppl 1):93-9.<br />
49. Lee EH, Nicolas MH, Kitzis MD, et al. Association of two resistance mechanisms<br />
in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.<br />
Antimicrob Agents Chemother 1991;35:1093-8.<br />
52
Change language